<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26874619</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-4457</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Lancet. Infectious diseases</Title><ISOAbbreviation>Lancet Infect Dis</ISOAbbreviation></Journal><ArticleTitle>The global burden of dengue: an analysis from the Global Burden of Disease Study 2013.</ArticleTitle><Pagination><StartPage>712</StartPage><EndPage>723</EndPage><MedlinePgn>712-723</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1473-3099(16)00026-8</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1473-3099(16)00026-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Dengue is the most common arbovirus infection globally, but its burden is poorly quantified. We estimated dengue mortality, incidence, and burden for the Global Burden of Disease Study 2013.</AbstractText><AbstractText Label="METHODS">We modelled mortality from vital registration, verbal autopsy, and surveillance data using the Cause of Death Ensemble Modelling tool. We modelled incidence from officially reported cases, and adjusted our raw estimates for under-reporting based on published estimates of expansion factors. In total, we had 1780 country-years of mortality data from 130 countries, 1636 country-years of dengue case reports from 76 countries, and expansion factor estimates for 14 countries.</AbstractText><AbstractText Label="FINDINGS">We estimated an average of 9221 dengue deaths per year between 1990 and 2013, increasing from a low of 8277 (95% uncertainty estimate 5353-10 649) in 1992, to a peak of 11&#x2008;302 (6790-13&#x2008;722) in 2010. This yielded a total of 576&#x2008;900 (330&#x2008;000-701&#x2008;200) years of life lost to premature mortality attributable to dengue in 2013. The incidence of dengue increased greatly between 1990 and 2013, with the number of cases more than doubling every decade, from 8&#xb7;3 million (3&#xb7;3 million-17&#xb7;2 million) apparent cases in 1990, to 58&#xb7;4 million (23&#xb7;6 million-121&#xb7;9 million) apparent cases in 2013. When accounting for disability from moderate and severe acute dengue, and post-dengue chronic fatigue, 566&#x2008;000 (186&#x2008;000-1&#x2008;415&#x2008;000) years lived with disability were attributable to dengue in 2013. Considering fatal and non-fatal outcomes together, dengue was responsible for 1&#xb7;14 million (0&#xb7;73 million-1&#xb7;98 million) disability-adjusted life-years in 2013.</AbstractText><AbstractText Label="INTERPRETATION">Although lower than other estimates, our results offer more evidence that the true symptomatic incidence of dengue probably falls within the commonly cited range of 50 million to 100 million cases per year. Our mortality estimates are lower than those presented elsewhere and should be considered in light of the totality of evidence suggesting that dengue mortality might, in fact, be substantially higher.</AbstractText><AbstractText Label="FUNDING">Bill &amp; Melinda Gates Foundation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stanaway</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA. Electronic address: stanaway@uw.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shepard</LastName><ForeName>Donald S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Undurraga</LastName><ForeName>Eduardo A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halasa</LastName><ForeName>Yara A</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coffeng</LastName><ForeName>Luc E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Oliver J</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Simon I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedi</LastName><ForeName>Neeraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>College of Public Health and Tropical Medicine, Jazan University, Jazan, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bensenor</LastName><ForeName>Isabela M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>University of S&#xe3;o Paulo, Hospital Universit&#xe1;rio, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casta&#xf1;eda-Orjuela</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Colombian National Health Observatory, Bogot&#xe1;, DC, Colombia; Epidemiology and Public Health Evaluation Group, Public Health Department, Universidades Nacional de Colombia, Ciudad Universitaria, Facultad de Medicina, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Ting-Wu</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Taipei Medical University, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibney</LastName><ForeName>Katherine B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Melbourne Health, Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Memish</LastName><ForeName>Ziad A</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Saudi Ministry of Health, Prince Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafay</LastName><ForeName>Anwar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Contech International Health Consultants, Lahore, Pakistan; Contech School of Public Health, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukwaja</LastName><ForeName>Kingsley N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yonemoto</LastName><ForeName>Naohiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Christopher J L</ForeName><Initials>CJL</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>095066</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lancet Infect Dis</MedlineTA><NlmUniqueID>101130150</NlmUniqueID><ISSNLinking>1473-3099</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Infect Dis. 2016 Jun;16(6):629-631</RefSource><PMID Version="1">26874620</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Infect Dis. 2016 Oct;16(10):1113-1114</RefSource><PMID Version="1">27676350</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006233" MajorTopicYN="N">Disabled Persons</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071219" MajorTopicYN="N">Global Burden of Disease</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019057" MajorTopicYN="Y">Quality-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">EMS69753</OtherID><CoiStatement>Declaration of interests LEC, CJLM, and JDS, have received grants from Bill &amp; Melinda Gates Foundation, during the study; KBG received a 2011 Gustav Nossal Postgraduate Scholarship sponsored by CSL Behring. EAU and DSS have received grants from Sanofi Pasteur. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26874619</ArticleId><ArticleId IdType="mid">EMS69753</ArticleId><ArticleId IdType="pmc">PMC5012511</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(16)00026-8</ArticleId><ArticleId IdType="pii">S1473-3099(16)00026-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brady OJ, Gething PW, Bhatt S, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6:e1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413714</ArticleId><ArticleId IdType="pubmed">22880140</ArticleId></ArticleIdList></Reference><Reference><Citation>DengueNet.  [accessed April 24, 2015];WHO.   http://www.who.int/csr/disease/dengue/denguenet/en/</Citation></Reference><Reference><Citation>World Health Organization. Vector borne and neglected tropical diseases. SEARO;  [accessed June 24, 2015].   http://www.searo.who.int/entity/vector_borne_tropical_diseases/en/</Citation></Reference><Reference><Citation>PAHO. Number of Reported Cases of Dengue and Severe Dengue in the Americas, by Country. 2014 published online June 5  http://www.paho.org/hq/index.php?option=com_topics&amp;view=readall&amp;cid=3273&amp;Itemid=40734&amp;lang=en.</Citation></Reference><Reference><Citation>WPRO. Annual Dengue Data in the Western Pacific Region. WPRO;  [accessed June 24, 2015].   http://www.wpro.who.int/emerging_diseases/annual.dengue.data.wpr/en/</Citation></Reference><Reference><Citation>Dengue.  [accessed April 10, 2015];WHO.   http://www.who.int/denguecontrol/en/</Citation></Reference><Reference><Citation>Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of Dengue.  [accessed April 24, 2015];WHO.   http://www.who.int/csr/disease/dengue/impact/en/</Citation></Reference><Reference><Citation>Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990&#x2013;2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380:2163&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350784</ArticleId><ArticleId IdType="pubmed">23245607</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue. N Engl J Med. 2012;366:1423&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Undurraga EA, Halasa YA, Shepard DS. Use of Expansion Factors to Estimate the Burden of Dengue in Southeast Asia: A Systematic Analysis. PLoS Negl Trop Dis. 2013;7:e2056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3578761</ArticleId><ArticleId IdType="pubmed">23437407</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepard DS, Undurraga EA, Betancourt-Cravioto M, et al. Approaches to refining estimates of global burden and economics of dengue. PLoS Negl Trop Dis. 2014;8:e3306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4238988</ArticleId><ArticleId IdType="pubmed">25412506</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray Christopher JL, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990&#x2013;2013: quantifying the epidemiological transition. Lancet. 2015 Aug 26; doi: 10.1016/S0140-6736(15)61340-X. Advance online publication.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)61340-X</ArticleId><ArticleId IdType="pmc">PMC4673910</ArticleId><ArticleId IdType="pubmed">26321261</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos Theo, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561509</ArticleId><ArticleId IdType="pubmed">26063472</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age&#x2013;sex specific all-cause and cause-specific mortality for 240 causes of death, 1990&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;385:117&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4340604</ArticleId><ArticleId IdType="pubmed">25530442</ArticleId></ArticleIdList></Reference><Reference><Citation>Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315398</ArticleId><ArticleId IdType="pubmed">22226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon JA. New disability weights for the global burden of disease. Bull World Health Organ. 2010;88:879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995197</ArticleId><ArticleId IdType="pubmed">21124707</ArticleId></ArticleIdList></Reference><Reference><Citation>Haagsma JA, de Noordhout CM, Polinder S, et al. Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr. 2015;13:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4715333</ArticleId><ArticleId IdType="pubmed">26778920</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol. 2007;5:518&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">17558424</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control, New edition. Geneva: World Health Organization; 2010.</Citation></Reference><Reference><Citation>Teixeira L de AS, Lopes JSM, da Martins AGC, Campos FAB, Miranzi S de SC, Nascentes GAN. Persistence of dengue symptoms in patients in Uberaba, Minas Gerais State, Brazil. Cad Sa&#xfa;de P&#xfa;blica. 2010;26:624&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">20464080</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ, Ooi EE, Vasudevan S, Farrar J, editors. Dengue and Dengue Hemorrhagic Fever. 2 edition. Wallingford, Oxfordshire; Boston, MA: CABI; 2014.</Citation></Reference><Reference><Citation>Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic Impact of Dengue Illness in the Americas. Am J Trop Med Hyg. 2011;84:200&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3029168</ArticleId><ArticleId IdType="pubmed">21292885</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar L, Dayan GH, Arredondo-Garc&#xed;a JL, et al. Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America. New England Journal of Medicine. 2015;372:113&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25365753</ArticleId></ArticleIdList></Reference><Reference><Citation>Capeding MR, Tran NH, Hadinegoro SRS, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. The Lancet. 2014;384:1358&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">25018116</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger JR, Ooi EE, Kelly DW, Woolhouse ME, Davies CR, Coleman PG. Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control. Bull World Health Organ. 2008;86:187&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2647409</ArticleId><ArticleId IdType="pubmed">18368205</ArticleId></ArticleIdList></Reference><Reference><Citation>PAHO/WHO. Five-fold increase in dengue cases in the Americas over the past decade.  [accessed April 14, 2015];2014  published online May 29  http://www.paho.org/hq/index.php?option=com_content&amp;view=article&lt;id=9657%3Alos-casos-de-dengue-en-las-americas-se-quintuplicaron-en-diez-anos-segun-nuevos-datos-de-la-opsoms&amp;Itemid=1926&amp;lang=en.</Citation></Reference><Reference><Citation>Tomashek KM.  The Acute Febrile Illness Surveillance Study in Puerto Rico: Findings from the First Two Years. Idsa; 2014.  [accessed June 24, 2015].   https://idsa.confex.com/idsa/2014/webprogram/Paper47354.html.</Citation></Reference><Reference><Citation>Senn N, Luang-Suarkia D, Manong D, Siba PM, McBride WJH. Contribution of dengue fever to the burden of acute febrile illnesses in Papua New Guinea: an age-specific prospective study. Am J Trop Med Hyg. 2011;85:132&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3122357</ArticleId><ArticleId IdType="pubmed">21734138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chairulfatah A, Setiabudi D, Ridad A, Colebunders R. Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia. Ann Soci&#xe9;t&#xe9; Belge M&#xe9;decine Trop. 1995;75:291&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8669976</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai N, Dorigatti I, Cauchemez S, Ferguson NM. Estimating Dengue Transmission Intensity from Sero-Prevalence Surveys in Multiple Countries. PLoS Negl Trop Dis. 2015;9:e0003719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4400108</ArticleId><ArticleId IdType="pubmed">25881272</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>